Skip to main content
. Author manuscript; available in PMC: 2014 Feb 18.
Published in final edited form as: Haemophilia. 2012 Jul 20;18(6):941–947. doi: 10.1111/j.1365-2516.2012.02896.x

Fig. 2.

Fig. 2

Whole blood clotting time (WBCT) plotted against the observed plasma concentration of turoctocog alfa (black) or N8-GP (red) after intravenous administration of 125 U kg−1 to haemophilic dogs (n = 3). Lines represent model fit, open circles the individual observed plasma concentration levels.